RSC Advances · 2014 · 34 citations · 42 references
PharmacyBioengineeringBiomedical EngineeringDrug DeliveryNanomaterialsNanoparticle Drug DeliveryCancer NanomedicineContrast AgentsInorganic NanoparticlesMagnetic Resonance ImagingNanomedicineTheranostic NanoparticlesBiomedical ApplicationsContrast EnhancementMesoporous Silica NanoparticlesNanoparticle Contrast AgentsNanoparticle Imaging AgentsNanoparticle Imaging ProbesNanoparticlesPhotoluminescence
We describe a simple method for synthesizing mesoporous silica-coated luminescent europium-doped gadolinium vanadate (GdVO4:Eu3+@mSiO2) nanoparticles. Their biomedical applications as a potential imaging nanoprobe for both fluorescence imaging and magnetic resonance imaging (MRI) and as a simultaneous anti-cancer drug delivery vehicle are also discussed. Eu3+ doped GdVO4 nanoparticles exhibit strong red photoluminescence and the Gd3+ in GdVO4 can be used as a T1 contrast agent for MRI. T1-weighted MR contrast enhancement as well as sustained intracellular drug delivery can be achieved by the mesoporous silica layer coating onto a single nanoparticle. Enhanced T1 MR contrast was proven by relaxometric studies on water access to the paramagnetic core. GdVO4:Eu3+@mSiO2 nanoparticles as a new type of theragnostic (imaging and treatment) agent can provide new opportunities in a cancer treatment.
42
Inorganic Nanoparticles for MRI Contrast Agents
Hyon Bin Na, In Chan Song, Taeghwan Hyeon · Advanced Materials · 2009 · 1.8K citations
Jaeyun Kim, Hoe Suk Kim, Nohyun Lee et al. · Angewandte Chemie International Edition · 2008 · 1.2K citations · Full text